Displaying items by tag: division of pulmonary allergy and critical care medicine

In findings published April 9 in Science Translational Medicine, the UAB team describes the mechanism that contributes to persistent fibrosis in the aged, and suggests targets that may help reverse the buildup of scar tissue.
UAB employing ECMO technology to treat severe cases of the flu when conventional therapy fails.
UAB offers U.S. Preventive Services Task Force-recommended CT scans for lung cancer, the leading cause of cancer deaths in the United States, causing more deaths than breast, colon and prostate cancer combined.

UAB investigators have found a new pathway that contributes to an often fatal lung disease with no cure and no effective treatments, and possibly a way to shut that pathway down.

UAB treated the first patient in the nation in an experimental lung reduction procedure for emphysema.

UAB Hospital participating in Centers for Medicare and Medicaid Services initiative designed to improve patient care, lower health care costs

CT scans can help physicians predict which COPD patients are likely to take a turn for the worse, say UAB researchers.

A new drug that improves lung function for some patients with cystic fibrosis may also help treat smokers with the incurable lung disease COPD.

The Program in Environmental and Translational Medicine combines clinical care with research to prevent, treat diseases caused from air pollution, water contamination, other causes.

UAB doctors can now employ a new procedure, using thermal energy, to open constricted airways in patients whose severe asthma is not controlled by medication.

UAB was a lead site in the testing of Kalydeco, the first drug to target the underlying genetic causes of cystic fibrosis.

A UAB researcher has received a grant to study idiopathic pulmonary fibrosis.

UAB is the first in the state to offer new procedure that uses thermal energy to help keep airways flowing freely.

Page 6 of 6